However, the largest Phase IIb trial involving 536 participants failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading to development termination in 2007
Have dull, tired, or uneven skin tone Want to lighten pigmentation and improve brightness Feel fatigued or low in energy Wish to detoxify and support liver health Desire anti-ageing, immune, or wellness support This treatment is safe, non-invasive, and suitable for both men and women of all skin types
However, the human body prefers a state of equilibrium, not excess
No crash
Follow-up Re-check glucose markers and relevant metabolic markers after 4-8 weeks or sooner if symptoms change
A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice